pharma · Heart Failure · Atrial Fibrillation · RYTM
Rhythm Pharmaceuticals Netherlands
Rhythm Pharmaceuticals Netherlands B.V.
Rhythm Pharmaceuticals Netherlands clinical programs — 10 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- BRIGHTLANDS CHEMELOT CAMPUS, VAN ITERSON BUILDING, BURGEMEESTER LEMMENSSTRAAT 352, Geleen, nl
- Founded
- 2014
- Employees
- 10
- Programs
- 73
- Drugs
- 38
- Patents
- 12
Rhythm Pharmaceuticals Netherlands projects
10 ClinicalTrials.gov programs sponsored by Rhythm Pharmaceuticals Netherlands.
Rhythm Pharmaceuticals Netherlands has 10 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Ablation procedure and/or cardioversion
Rhythm Pharmaceuticals Netherlands B.V.
Atrial Fibrillation
1 trial -
Baroreceptor Stimulation
Rhythm Pharmaceuticals Netherlands B.V.
Hypertension
1 trial -
Bupivacaine alone OR Bupivacaine-Ketorolac-Ketamine (BKK) Combination
Rhythm Pharmaceuticals Netherlands B.V.
Pain Management
1 trial -
Cardiac Resynchronization Therapy
Rhythm Pharmaceuticals Netherlands B.V.
Heart Failure
1 trial -
MARVEL algorithm
Rhythm Pharmaceuticals Netherlands B.V.
Atrioventricular Conduction Block
1 trial -
Pacing Lead
Rhythm Pharmaceuticals Netherlands B.V.
Heart Failure
1 trial -
Placebo
Rhythm Pharmaceuticals Netherlands B.V.
Obesity
1 trial -
RM-493
Rhythm Pharmaceuticals Netherlands B.V.
Overweight
1 trial -
Setmelanotide
Rhythm Pharmaceuticals Netherlands B.V.
Renal Insufficiency
1 trial -
Vagal Nerve Stimulation
Rhythm Pharmaceuticals Netherlands B.V.
Inflammation
1 trial
Frequently asked questions
How many clinical projects does Rhythm Pharmaceuticals Netherlands have?
10 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.